文献速递神经肿瘤

MicroRNA-211在人脑胶质瘤中表达下调且与不良预后相关

MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
PubMed 文献 · J Neurooncol · 2017-05-27

研究检测82例胶质瘤及瘤旁正常脑组织中miR-211表达,发现胶质瘤组织表达显著低于瘤旁正常组织(3.52±0.14 vs 4.96±0.17,p<0.001),且与WHO分级递增呈负相关(III-IV级3.16±0.21 vs I-II级4.22±0.26,p<0.001);miR-211低表达与总生存期缩短相关(p=0.026),多因素Cox回归显示WHO分级、KPS和miR-211表达水平为独立预后危险因素。

要点

  • 胶质瘤组织miR-211表达显著低于瘤旁正常脑组织(3.52±0.14 vs 4.96±0.17,p<0.001)
  • miR-211表达与WHO分级递增呈负相关(III-IV级3.16±0.21 vs I-II级4.22±0.26,p<0.001)
  • miR-211低表达与总生存期缩短相关(p=0.026),为独立预后危险因素(HR=3.614)

核心结论

  • miR-211低表达可能是胶质瘤患者不良预后的标志物。

研究设计与样本

  • 研究纳入82例接受手术切除的胶质瘤患者,获取胶质瘤组织及瘤旁正常脑组织,采用实时定量聚合酶链反应检测miR-211表达水平。

主要发现

  • 胶质瘤组织miR-211表达显著低于瘤旁正常脑组织(胶质瘤3.52±0.14 vs 正常4.96±0.17,p<0.001)。
  • miR-211表达与WHO分级递增呈负相关(III-IV级3.16±0.21 vs I-II级4.22±0.26,p<0.001)。
  • miR-211低表达与82例患者较短生存时间密切相关(p=0.026)。
  • 多因素Cox回归显示WHO分级(HR=2.437,95%CI 1.251-4.966,p=0.007)、KPS(HR=2.215,95%CI 1.168-4.259,p=0.016)和miR-211表达水平(HR=3.614,95%CI 2.152-6.748,p<0.001)为胶质瘤预后的独立危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Accumulating evidence has supported the role of microRNAs in the initiation and development of malignant tumors. MicroRNA-211 (miR-211), which was reported to involve in diverse physiological activities in several cancers, was investigated for its expression in human glioma and adjacent normal brain tissues, as well as its correlation with patient prognosis. Glioma tissues and adjacent normal brain tissues were obtained from 82 patients who underwent surgical resection, and quantitative real-time polymerase chain reaction was performed to assess the expression level of miR-211. Here, we found that miR-211 was significantly decreased in glioma tissues compared with adjacent normal brain tissues (glioma, 3.52 ± 0.14 vs. normal, 4.96 ± 0.17, p < 0.001), and inversely associated with ascending WHO classification (grade III-IV, 3.16 ± 0.21 vs. grade I-II, 4.22 ± 0.26, p < 0.001). Then, the correlation of miR-211 with clinicopathological factors was investigated by Pearson's Chi square test, indicating that miR-211 might be a potential biomarker to predict the malignant status of glioma. Further, Kaplan-Meier curves with log-rank analysis were carried out to determine the relationship between miR-211 expression level and the overall survival rate of glioma patients. Our data showed that there was a close correlation between down-regulated miR-211 and shorter survival time in 82 patients (p = 0.026). Finally, the multivariate Cox regression analysis indicated that WHO grade (HR = 2.437, 95% CI 1.251-4.966, p = 0.007), KPS (HR = 2.215, 95% CI 1.168-4.259, p = 0.016), and miR-211 expression level (HR = 3.614, 95% CI 2.152-6.748, p < 0.001) were considered as independent risk factors for glioma prognosis. These results suggested that lower miR-211 expression might be a marker for poor prognosis of glioma patients.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Lv J, Zhang F, et al. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma. J Neurooncol. 2017. PMID: 28551850. doi:10.1007/s11060-017-2464-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。